Skip to main content

James E. Kendrick, MD

James E. Kendrick , MD

Obstetrician-gynecologist

Cancer

James Kendrick

Overview

Dr. James E Kendrick, MD, FACOG is board certified in gynecology oncologist in Orlando. Dr. Kendrick joined the Gynecologic Oncology Program at the Florida Hospital Cancer Institute in July of 2009. He graduated with honors from the University of Alabama School of Medicine. Dr. Kendrick then completed a four year residency in obstetrics and gynecology followed by a three year fellowship in gynecologic oncology at The University of Alabama at Birmingham. Dr. Kendrick is widely published in numerous academic journals, and currently serves as the principal investigator for all Gynecologic Oncology Group clinical trials available to our patients. His clinical interests include robotic surgery and the surgical and medical management of all gynecologic malignancies.

Articles

Clinical outcomes analysis of neoadjuvant chemotherapy for locally advanced vulvar cancer

Gynecologic oncology

2023

Analysis of "sandwich" chemo-radiation therapy for stage IIIC endometrial cancer

Gynecologic oncology

2023

Malignant peritoneal cytologic contamination with robotic hysterectomy for endometrial cancer

Gynecologic oncology

2023

Clinical Activity of Olvimulogene Nanivacirepvec-Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer The Nonrandomized Phase 2 VIRO-15 Clinical Trial

JAMA ONCOLOGY

2023

Corrigendum to "A phase 1b study of intraperitoneal oncolytic viral immunotherapy in platinum-resistant or refractory ovarian cancer" [Gynecologic Oncology 163 (2021) 481-489].

Gynecologic oncology

2022

MALIGNANT PERITONEAL CYTOLOGIC CONTAMINATION WITH ROBOTIC HYSTERECTOMY FOR ENDOMETRIAL CANCER

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

2022

Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial

CLINICAL CANCER RESEARCH

2022

Search for Lepton-Flavor Violation in Z-Boson Decays with tau Leptons with the ATLAS Detector

PHYSICAL REVIEW LETTERS

2021

A phase 1b study of intraperitoneal oncolytic viral immunotherapy in platinum-resistant or refractory ovarian cancer

Gynecologic oncology

2021

ASO Visual Abstract: Carcinomatosis in Early-Stage Cervical Cancer Treated with Robotic Radical Hysterectomy-Recurrence Patterns, Risk Factors, and Survival

ANNALS OF SURGICAL ONCOLOGY

2021

Education & Training

Education

University of Alabama School of Medicine, Birmingham, AL

Residency

University of Alabama at Birmingham, AL

Fellowship

University of Alabama at Birmingham, AL

Specialty

Gynecology Oncology

Board Certifications

American Board of Obstetrics & Gynecology